Free Trial

Leap Therapeutics (LPTX) SEC Filings & 10K Form

Leap Therapeutics logo
$2.59 -0.11 (-4.07%)
(As of 11/20/2024 ET)

Recent Leap Therapeutics SEC Filings

DateFilerForm TypeView
11/15/2024
4:28 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:29 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:30 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:31 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
5:07 AM
BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Leap Therapeutics (Subject)
Form SC 13G
11/13/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
5:29 PM
BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
Form SC 13D/A
10/31/2024
4:40 PM
BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
Form SCHEDULE 13D/A
10/04/2024
4:22 PM
Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:23 PM
Baum Jason (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:23 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:23 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:25 PM
Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:25 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:25 PM
Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:26 PM
Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:27 PM
Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:29 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:29 PM
Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:30 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
3:48 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
11:15 PM
Leap Therapeutics (Filer)
Form EFFECT
05/13/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
4:01 PM
Leap Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/09/2024
11:15 PM
Leap Therapeutics (Filer)
Form EFFECT
04/29/2024
3:34 PM
Leap Therapeutics (Filer)
Form DEFA14A
04/29/2024
3:37 PM
Leap Therapeutics (Filer)
Form ARS
04/25/2024
7:39 PM
Leap Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SC 13G
04/19/2024
3:31 PM
GILEAD SCIENCES, INC. (Reporting)
Leap Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/19/2024
3:31 PM
GILEAD SCIENCES, INC. (Filed by)
Leap Therapeutics (Subject)
Form SC 13G
04/11/2024
7:42 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
6:41 AM
Leap Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/18/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

03/18/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/31/2024
8:34 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:34 PM
Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:34 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:34 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:35 PM
Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:35 PM
Baum Jason (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:35 PM
Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:36 PM
Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:36 PM
Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:37 PM
Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:31 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:32 PM
Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:32 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:33 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:33 PM
Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:37 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:38 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:39 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:41 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:42 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
4:28 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
4:10 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LPTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners